Accurate detection of respiratory viruses and subtypes is critical for patient care management, disease surveillance, and infection control practices. Detect multiple respiratory viruses, the majority of which readily circulate among the most vulnerable populations—children, the elderly, and the immunocompromised—with xTAG® Respiratory Viral Panel (RVP) FAST v2.
For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.
*Only xTAG RVP FAST v2 can be used on our MAGPIX system.
Intended Use (EU-IVD/SFDA Approved):
The xTAG® Respiratory Viral Panel Fast v2 (RVP FAST v2) is a qualitative nucleic acid multiplex test intended for the simultaneous detection and identification of multiple respiratory virus nucleic acids in nasopharyngeal swabs, nasal aspirates and bronchioalveolar lavages from individuals suspected of respiratory tract infections.
The detection and identification of specific viral nucleic acids from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection when used in conjunction with other clinical and laboratory findings.